IMO-9200

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameIMO-9200
Drug Alias NameIMO-9200
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 7 antagonistsToll like receptor 8 antagonistsToll like receptor 9 antagonists
TargetsToll like receptor 8Toll like receptor 9Toll like receptor 7
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIdera
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIderaVivelix Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A